Literature DB >> 21036250

Measurement of constitutive MAPK and PI3K/AKT signaling activity in human cancer cell lines.

Kim H T Paraiso1, Kaisa Van Der Kooi, Jane L Messina, Keiran S M Smalley.   

Abstract

The growth and survival of cancer cells are often driven by constitutive activity in the mitogen-activated protein kinase (MAPK) and phospho-inositide 3-kinase (PI3K)/AKT signaling pathways. Activity in these signal transduction cascades is known to contribute to the uncontrolled growth and resistance to apoptosis that characterizes tumor progression. There is now a great deal of interest in therapeutically targeting these pathways in cancer using small molecule inhibitors. In this chapter, we describe methods to measure constitutive MAPK and AKT activity in melanoma cell lines, with a focus upon Western blotting, phospho-flow cytometry, and immunofluorescence staining techniques.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036250      PMCID: PMC4001792          DOI: 10.1016/B978-0-12-381298-8.00027-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  36 in total

Review 1.  The RAF proteins take centre stage.

Authors:  Claudia Wellbrock; Maria Karasarides; Richard Marais
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

2.  Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

Authors:  S R Datta; H Dudek; X Tao; S Masters; H Fu; Y Gotoh; M E Greenberg
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

Review 3.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

4.  Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases.

Authors:  Keiran S M Smalley; Nikolas K Haass; Patricia A Brafford; Mercedes Lioni; Keith T Flaherty; Meenhard Herlyn
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

5.  Mutant PIK3CA promotes cell growth and invasion of human cancer cells.

Authors:  Yardena Samuels; Luis A Diaz; Oleg Schmidt-Kittler; Jordan M Cummins; Laura Delong; Ian Cheong; Carlo Rago; David L Huso; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

Review 6.  Ternary complex factors: growth factor regulated transcriptional activators.

Authors:  R Treisman
Journal:  Curr Opin Genet Dev       Date:  1994-02       Impact factor: 5.578

7.  Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.

Authors:  Kavita V Bhatt; Laurie S Spofford; Gazelle Aram; Meghan McMullen; Kevin Pumiglia; Andrew E Aplin
Journal:  Oncogene       Date:  2005-05-12       Impact factor: 9.867

Review 8.  Functional and therapeutic significance of Akt deregulation in malignant melanoma.

Authors:  Gavin P Robertson
Journal:  Cancer Metastasis Rev       Date:  2005-06       Impact factor: 9.264

9.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Victor E Velculescu
Journal:  Cell Cycle       Date:  2004-10-12       Impact factor: 4.534

10.  Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts.

Authors:  P Lenormand; C Sardet; G Pagès; G L'Allemain; A Brunet; J Pouysségur
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

View more
  3 in total

1.  Signet-ring Cells in the Skin: A Case of Late-onset Cutaneous Metastasis of Gastric Carcinoma and a Brief Review of Histological Approach.

Authors:  Özgür Gündüz; Mehmet Can Emeksiz; Pinar Atasoy; Mehtap Kidir; Selim Yalçin; Serkan Demirkan
Journal:  Dermatol Reports       Date:  2017-01-04

2.  Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway.

Authors:  Ruiwei Wang; Zihao Zhang; Mukesh Kumar; Guangming Xu; Mengyuan Zhang
Journal:  Drug Des Devel Ther       Date:  2019-02-04       Impact factor: 4.162

3.  An Integrated Proteomics and Bioinformatics Analysis of the Anticancer Properties of RT2 Antimicrobial Peptide on Human Colon Cancer (Caco-2) Cells.

Authors:  Surachai Maijaroen; Sompong Klaynongsruang; Sittiruk Roytrakul; Monruedee Konkchaiyaphum; Lapatrada Taemaitree; Nisachon Jangpromma
Journal:  Molecules       Date:  2022-02-20       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.